MedTrace Logo

the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

NCT05126446 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-07-23

No results posted yet for this study

Summary

A prospective, multi-center, single-group target value method to evaluate the safety and effectiveness of the Aorta Arch Stent Graft System combined with the Endovascular Needle System in situ fenestration technology in the treatment of aortic dissection involving the aortic arch

Conditions

  • Aortic Dissection

Interventions

DEVICE

the Aorta Arch Stent Graft System combined with the Endovascular Needle System

Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with device

Sponsors & Collaborators

  • Lifetech Scientific (Shenzhen) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chang Shu, Professor · Xiangya Second Hospital, Central South University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-25
Primary Completion
2027-10-30
Completion
2028-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126446 on ClinicalTrials.gov